-Firstpost.com Bhupesh Roy is from Assam but he is a long way from home. He has been working in the southern state of Kerala in the construction sector for the past four years and earns around Rs 500 a day, for an average of 20 days a month. “Two months ago, I fell sick. I had food poisoning and was admitted to hospital. I had fever too. For a week, I...

-The Telegraph New Delhi: The government's price cap on coronary stents has not deterred the health-care industry from continuing to offer hospitals profit opportunities of tens of thousands of rupees on other kinds of stents, concerned doctors and health-care industry representatives said.     The National Pharmaceutical Pricing Authority (NPPA), the government's price regulator, had on February 15 imposed a cap of about Rs 30,000 on coronary stents. But hospitals can continue to...

-The Hindu Business Line Prime Minister Narendra Modi promised one crore jobs during the 2014 elections. At the present rate of job creation, this will take 30 years. Muthukumar K and Seetharaman R report on the employment crisis Raj Abraham (name changed on request), a first-year student at a leading management institute in Chennai, is a bit anxious these days. Ask him how his seniors are faring in campus placement and the...

-The Indian Express Prime Minister Narendra Modi wants doctors to prescribe generic medicines over branded ones. KAUNAIN SHERIFF M answers key questions on the pricing of drugs and beyond. * What exactly has Prime Minister Narendra Modi said on generic drugs? Speaking in Surat on April 17, the Prime Minister referred to the Pradhan Mantri Bharatiya Janaushadhi Pariyojana (PMBJP), which aims to provide cheaper medical drugs to the people. “In the coming days,...

-The Telegraph New Delhi: Regulatory efforts to get doctors in India to prescribe medicines only through their generic names, initiated about 15 years ago, will need to overcome legal challenges and resistance from sections of doctors and the pharmaceutical industry, experts said. Senior pharmacologists and industry analysts have also said it will be misleading to presume that prescriptions with generic names will automatically translate into lower medicine bills for patients as studies...